#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Central nervous system neoplasm Acquired C1 inhibitor deficiency Bronchopulmonary dysplasia Biliary cancer metastatic Primary myelofibrosis Thrombocytosis Prader-Willi syndrome Neuroendocrine tumour of the lung Oesophageal achalasia Asthma Primary hyperoxaluria Familial hypertriglyceridaemia Toxic epidermal necrolysis Haemophilia B without inhibitors More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Life with Disease Osteosarcoma – Basic Information Immunodeficiency congenital – Life with Disease Chondrosarcoma metastatic Acquired haemophilia – Trials in Disease Primary biliary cholangitis – Life with Disease Combined immunodeficiency Leiomyosarcoma recurrent – Treatment Urea cycle disorder – Trials in Disease Alternating hemiplegia of childhood More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methionine Carbasalate Calcium Tilmanocept Db-Oto-5 Tranexamic Acid Axatilimab Vilobelimab Trametinib Salmeterol Nomegestrol Acetate Binimetinib Sacituzumab Govitecan D-Camphor Dronabinol Erythromycin Lactobionate Immunoglobulin A Vancomycin Hydrochloride Sacubitril Valsartan Bevacizumab LUNRESERTIB More therapies…

    Learn about Your Condition

    Adrenocortical carcinoma Cystic fibrosis lung End stage renal disease Carcinoid syndrome Notalgia paraesthetica Breast cancer stage IV Acquired ATTR amyloidosis Fatty acid oxidation disorder Anal squamous cell carcinoma Skin neoplasm excision Hernia repair Craniotomy Mantle cell lymphoma stage II Lichen sclerosus Irritable bowel syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Doxycycline post‑exposure prophylaxis for sexually transmitted infections in MSM and transgender women on antiretroviral drug combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Doxycycline
    • Bictegravir
    Spain

  • Safety and Pharmacokinetics of MIB2 (StaphAcute) in Healthy Volunteers and Patients with Staphylococcus aureus Bacteremia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Sodium Chloride
    Germany

  • Early switch to oral amoxicillin (drug combination) for adults with vertebral osteomyelitis: a randomised non‑inferiority trial

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefalexin
    • Ciprofloxacin
    • Flucloxacillin
    Germany

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rifabutin
    • SULBACTAM SODIUM
    • Ampicillin Sodium
    Croatia Greece

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Esomeprazole
    • Tetracycline Hydrochloride
    • Clarithromycin
    Greece

  • Acetylcysteine for Adults with Acute Infection or Sepsis and Liver Dysfunction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Acetylcysteine
    • Sodium Chloride
    Denmark
1 2 3 … 48
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!